Is adipose tissue lipolysis always an adaptive response to starvation?: Implications for non-alcoholic fatty liver disease

Clinical Science

Volumn 114, Issue 7-8, 2008, Pages 543-545

  Gan, Seng Khee ^a   Watts, Gerald F ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

3 hydroxybutyrate; 1H magnetic resonance spectroscopy; Fasting; Fatty liver; Lipid; Non alcoholic fatty liver disease (NAFLD)

Indexed keywords

3 HYDROXYBUTYRIC ACID; APOLIPOPROTEIN B100; FATTY ACID; LIPID;

ADIPOSE TISSUE; AMINO ACID COMPOSITION; ANOREXIA NERVOSA; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ESTERIFICATION; FATTY ACID OXIDATION; GLUCONEOGENESIS; HUMAN; INTRAHEPATIC LIPID CONTENT; KETOGENESIS; LIPID ANALYSIS; LIPID TRANSPORT; LIPOLYSIS; LIVER CIRCULATION; NONALCOHOLIC FATTY LIVER; NOTE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; OXIDATIVE STRESS; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RISK ASSESSMENT; STARVATION; WEIGHT REDUCTION; FATTY LIVER; LIVER; METABOLISM;

ADIPOSE TISSUE; FATTY LIVER; HUMANS; LIPOLYSIS; LIVER; STARVATION;

EID: 41949096766     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070461     Document Type: Note

References (20)

1. Cahill, G. F. (2006) Fuel metabolism in starvation. Annu. Rev. Nutr. 26, 1-22
2. Inagaki, T., Dutchak, P., Zhao, G. et al. (2007) Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415-425
3. Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S. and Maratos-Flier, E. (2007) Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5, 426-437
4. Wolfram, C., Asilmaz, E., Luca, E., Friedman, J. M. and Stoffel, M. (2004) Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432, 1027-1032
5. 1H-magnetic resonance spectroscopy. Clin. Sci. 114, 547-552
6. Roden, M. (2006) Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat. Clin. Pract. Endo. Metab. 2, 335-348
7. Begriche, K., Igoudjil, A., Pessayre, D. and Fromenty, B. (2006) Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6, 1-28
8. Cho, E. S., Sahyoun, N. and Stegink, L. D. (1981) Tissue glutathione as a cyst(e)ine reservoir during fasting and refeeding of rats. J. Nutr. 111, 914-922
9. Elia, M., Stubbs, R. J. and Henry, C. J. (1999) Differences in fat, carbohydrate, and protein metabolism between lean and obese subjects undergoing total starvation. Obes. Res. 7, 597-604
10. Hardie, D. G., Hawley, S. A. and Scott, J. W. (2006) AMP-activated protein kinase - development of the energy sensor concept. J. Physiol. 574, 7-15
11. Angulo, P. (2002) Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221-1231
12. Targher, G., Bertolini, L., Rodella, S. et al. (2007) Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 30, 2119-2121
13. Day, C. and James, O. (1998) Steatohepatitis: a tale of two 'hits'? Gastroenterology 114, 842-845
14. Westerbacka, J., Lammi, K., Häkkinen, A. M. et al. (2005) Dietary fat content modifies liver fat in overweight nondiabetic subjects. J. Clin. Endocrinol. Metab. 90, 2804-2809
15. Matikainen, N., Mänttäri, S., Westerbacka, J. et al. (2007) Postprandial lipemia associates with liver fat content. J. Clin. Endocrinol. Metab. 92, 3052-3059
16. Belfort, R., Harrison, S. A., Brown, K. et al. (2006) A placebo controlled trial of pioglitazone in subjects with non-alcoholic steatohepatitis. N. Engl. J. Med. 335, 2297-2307
17. McFarland, R., Gazet, J. and Pilkington, T. (1985) A 13 year review of jejunoileal bypass. Br. J. Surg. 72, 81-87
18. Grimm, I., Schindler, W. and Haluszka, O. (1992) Steatohepatitis and fatal hepatic failure after biliopancreatic diversion. Am. J. Gastroenterol. 87, 775-779
19. Sakada, M., Tanaka, A., Ohta, D. et al. (2006) Severe steatosis resulted from anorexia nervosa leading to fatal hepatic failure. J. Gastroenterol. 41, 714-715
20. Fisher, R. (1989) Hepatobiliary abnormalities associated with total parenteral nutrition. Gastroenterol. Clin. North Am. 18, 645-666